Evidence map›Paper›PMID 21576334›Full record

ArticleInfection and immunity2011

Klebsiella pneumoniae yersiniabactin promotes respiratory tract infection through evasion of lipocalin 2.

Michael A Bachman, Jennifer E Oyler, Samuel H Burns, Mélissa Caza, François Lépine, Charles M Dozois, Jeffrey N Weiser

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 187 papers.

0numbers the graph read from it
0cells of the map it votes in
187citing papers in PubMed
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

187 citing papers in PubMed, 309 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Sedative choice altersInfection and immunity · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Differential virulence potential of different clades of multidrug-resistantmedRxiv : the preprint server for health sciences · 2026
    Article
  11. Article
  12. Review
  13. Connections betweenInfection and immunity · 2026
    Article
  14. Article
  15. Article
  16. The acquisition ofmBio · 2026
    Article
  17. Article
  18. Article
  19. Frontiers in microbiology · 2026
    Review
  20. Review

127 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Michael A BachmanDepartment of Pathology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.
Jennifer E Oyler
Samuel H Burns
Mélissa Caza
François Lépine
Charles M Dozois
Jeffrey N Weiser
University of Pennsylvania · USArmand Frappier Museum · CA

Funding

ROLE OF OPACITY VARIATION IN PNEUMOCOCCAL PATHOGENESISR01AI038446 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI WEISER, JEFFREY NEAL · 1996 to 2019
$7.4M
Bacterial and host factors in pneumococcal competitionR01AI078538 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI WEISER, JEFFREY NEAL · 2009 to 2013
$1.9M
The host mucosal response to microbial iron metabolismK08GM085612 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI BACHMAN, MICHAEL ABBOTT · 2009 to 2013
$740k
NIAID NIH HHS R01 AI038446NIAID NIH HHS R01AI038446NIAID NIH HHS R01 AI078538NIAID NIH HHS R01AI078538NIGMS NIH HHS K08 GM085612NIGMS NIH HHS K08GM085612
6 · The paper itself

Abstract

Klebsiella pneumoniae is a pathogen of increasing concern because of multidrug resistance, especially due to K. pneumoniae carbapenemases (KPCs). K. pneumoniae must acquire iron to replicate, and it utilizes iron-scavenging siderophores, such as enterobactin (Ent). The innate immune protein lipocalin 2 (Lcn2) is able to specifically bind Ent and disrupt iron acquisition. To determine whether K. pneumoniae must produce Lcn2-resistant siderophores to cause disease, we examined siderophore production by clinical isolates (n = 129) from respiratory, urine, blood, and stool samples and by defined siderophore mutants through genotyping and liquid chromatography-mass spectrometry. Three categories of K. pneumoniae isolates were identified: enterobactin positive (Ent(+)) (81%), enterobactin and yersiniabactin positive (Ent(+) Ybt(+)) (17%), and enterobactin and salmochelin (glycosylated Ent) positive (Ent(+) gly-Ent(+)) with or without Ybt (2%). Ent(+) Ybt(+) strains were significantly overrepresented among respiratory tract isolates (P = 0.0068) and β-lactam-resistant isolates (P = 0.0019), including the epidemic KPC-producing clone multilocus sequence type 258 (ST258). In ex vivo growth assays, gly-Ent but not Ybt allowed evasion of Lcn2 in human serum, whereas siderophores were dispensable for growth in human urine. In a murine pneumonia model, an Ent(+) strain was an opportunistic pathogen that was completely inhibited by Lcn2 but caused severe, disseminated disease in Lcn2(-/-) mice. In contrast, an Ent(+) Ybt(+) strain was a frank respiratory pathogen, causing pneumonia despite Lcn2. However, Lcn2 retained partial protection against disseminated disease. In summary, Ybt is a virulence factor that is prevalent among KPC-producing K. pneumoniae isolates and promotes respiratory tract infections through evasion of Lcn2.

Indexed as

Acute-Phase ProteinsAnimalsBloodDisease Models, AnimalDNA, BacterialFecesHumansImmunologic FactorsKlebsiella InfectionsKlebsiella pneumoniaeLipocalin-2LipocalinsMass SpectrometryMiceMice, Inbred C57BLMice, KnockoutAcute-Phase ProteinsDNA, BacterialImmunologic FactorsLCN2 protein, humanLcn2 protein, mouseLipocalin-2LipocalinsOncogene ProteinsPhenolsProto-Oncogene ProteinsThiazolesVirulence Factorsyersiniabactin

Identifiers

PMID21576334
PMCPMC3147564
OpenAlexW2148920499

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.